Novartis Whistleblower Suit Over MS Drug Dismissed With Leave To Amend
NEW YORK — A New York federal judge on March 24 dismissed with leave to amend a false claims complaint alleging that Novartis Pharmaceuticals Corp. used a sham speaker program to...To view the full article, register now.
Already a subscriber? Click here to view full article